Tech Company Financing Transactions
Federation Bio Funding Round
Federation Bio, based in San Francisco, secured $50 million from Horizons Ventures, Altitude Capital Partners and Health for Life Capital Fund.
Transaction Overview
Company Name
Announced On
10/7/2020
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
280 Utah Ave.
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Federation Bio is pioneering new platforms that target diseases in which the human microbiome can play a curative role. The company's microbial approach leverages naturally occurring bacteria along with a diverse community of supportive bacteria to drive engraftment and durable therapeutic responses.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Emily Conley
Chief Scientific Officer
Lee Swem
Browse more venture capital transactions:
Prev: 10/7/2020: Nivelo venture capital transaction
Next: 10/7/2020: Talaris Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs